Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress

Figure 4 Immunohistochemistry for detection of α-SMA⁺ hepatic stellate cells in histological sections. A-D: Control (A), saline-treated (B), BMMCs-treated (C) and CD11b⁺CD14⁺ monocyte-treated (D) groups of mice (magnification × 200); E: Measurement of α-SMA⁺ hepatic stellate cells at 2 mo after treatment with CD11b⁺CD14⁺ monocytes and BMMCs. ^aP < 0.05; ^bP < 0.01. BMMCs: Bone marrow mononuclear cells.